Markus Muttenthaler

© Anjanette Webb

The medicinal chemist Markus Muttenthaler will henceforth be conducting research on new therapeutic approaches for gastrointestinal disorders at the Department of Biological Chemistry of the University of Vienna. Since 2015, he has been leading his own research group at the Institute for Molecular Bioscience in Brisbane (University of Queensland) on the basis of a highly respected Australian research grant. Muttenthaler will come to the University of Vienna in autumn 2017. In his ERC project, Muttenthaler will focus on new gastrointestinal wound healing mechanisms and, among others, assess the therapeutic potential of the receptor for the hormone oxytocin.